Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Andrew Haydon"'
Autor:
Joshua D. Cohen, Lisa Dobbyn, Desmond Yip, Jeanne Tie, Maria Popoli, Peter Gibbs, Bert Vogelstein, Yuxuan Wang, Cristian Tomasetti, Iain Skinner, Janine Ptak, Kenneth W. Kinzler, Hui-Li Wong, Christos S. Karapetis, Natalie Silliman, Suzanne Kosmider, Nickolas Papadopoulos, Matthew Burge, Mary J. Schaeffer, Timothy J. Price, Rachel Wong, Lu Li, Andrew Haydon, Belinda Lee, Margaret Lee, Niall C. Tebbutt, Serigne Lo, Michael Christie
Publikováno v:
Int J Cancer
Studies in multiple solid tumor types have demonstrated the prognostic significance of ctDNA analysis after curative intent surgery. A combined analysis of data across completed studies could further our understanding of circulating tumor DNA (ctDNA)
Autor:
Adnan Nagrial, David Goldstein, Niall C. Tebbutt, Bert Vogelstein, Joshua D. Cohen, Lu Li, Andrew Haydon, Kenneth W. Kinzler, Koen Simons, Peter Gibbs, Jeanne Tie, Cristian Tomasetti, D W M Tai, Prasad Cooray, Nick Papadopoulos, C L Wolfgang, Matthew Burge, Lara Lipton, Belinda Lee, Mehrdad Nikfarjam, Ammar A. Javed, Marion Harris, Benjamin N. J. Thomson, A M Lennon, B. Lawrence
Publikováno v:
Annals of Oncology. 30:1472-1478
In early-stage pancreatic cancer, there are currently no biomarkers to guide selection of therapeutic options. This prospective biomarker trial evaluated the feasibility and potential clinical utility of circulating tumor DNA (ctDNA) analysis to info
Autor:
Cristian Tomasetti, Dusan Kotasek, Bert Vogelstein, Craig Underhill, Suzanne Kosmider, Julian Choi, Peter Gibbs, Adrian Fox, Wei Hong, Yuxuan Wang, Hui-Li Wong, Jeanne Tie, Christos S Karapetis, Niall C. Tebbutt, Joy Schaeffer, Benjamin N. J. Thomson, Lu Li, Andrew Haydon, Matthew Burge, Joshua D. Cohen, Jenny Shannon, Janine Ptak, Michael Christie, Kenneth W. Kinzler, Kathryn M. Field, Nicholas Papadopoulos, Rachel Wong
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 18, Iss 5, p e1003620 (2021)
PLoS Medicine, Vol 18, Iss 5, p e1003620 (2021)
Background In patients with resectable colorectal liver metastases (CRLM), the role of pre- and postoperative systemic therapy continues to be debated. Previous studies have shown that circulating tumor DNA (ctDNA) analysis, as a marker of minimal re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffca5f1804285e3c3daa386a9dc7debe
Autor:
Katy K. Tsai, Ines Pires da Silva, Andrew Haydon, Rebecca A. Burrell, Adriana Hepner, Serigne Lo, Oliver Klein, James Larkin, Matteo S. Carlino, Megan Lyle, Camille L. Gerard, Alexander M. Menzies, Lisa Zimmer, Lalit Pallan, Victoria Atkinson, Georgina V. Long, Prachi Bhave, Douglas B. Johnson, Olivier Michielin
Publikováno v:
European journal of cancer (Oxford, England : 1990). 153
Purpose Combination immunotherapy with nivolumab and ipilimumab has a high initial response rate in advanced melanoma; however, up to 55% of patients later progress. The efficacy and safety of ipilimumab re-induction in the setting of acquired resist
Autor:
Evangeline Samuel, Mark Shackleton, Sagun Parakh, Paul Mitchell, Gabrielle Lie, Mark Voskoboynik, Adithya Balasubramanian, Thomas John, Ben Markman, Peter Briggs, Andrew Haydon, Maggie Moore, Alison Hiong, Yeojeong So
Publikováno v:
Clinical lung cancer. 22(3)
Background The impact of radiotherapy (RT) on the efficacy and toxicity of immune checkpoint inhibitors (ICIs) in patients with metastatic non–small-cell lung cancer (NSCLC) is unclear. Materials and Methods We identified patients with metastatic N
Autor:
Mark Nelson, John J McNeil, Peter Gibbs, Jeremy Millar, Brenda Kirpach, Ellen Richmond, Kathlyn J. Ronaldson, Asad Umar, Raj C. Shah, G J. Van Londen, Andrew Haydon, Leslie G. Ford, Christopher M. Reid, Galina Polekhina, Jeanne Tie, Jessica E. Lockery, Wendy B. Bernstein, Andrew T. Chan, Rory Wolfe, John Zalcberg, Suzanne G Orchard, L.M. Rodriguez, Anne M. Murray, Yin Cao, Catriona McLean, Robyn L. Woods, Finlay A. Macrae
Publikováno v:
Journal of the National Cancer Institute. 113(3)
Background ASPirin in Reducing Events in the Elderly, a randomized, double-blind, placebo-controlled trial of daily low-dose aspirin (100 mg) in older adults, showed an increase in all-cause mortality, primarily due to cancer. In contrast, prior rand
Autor:
Ian Porter, Trevor Leong, Paul Burton, Marty Smith, John Spillane, Mehrdad Nikfarjam, Michael W Hii, John J McNeil, John Zalcberg, Brett Knowles, Andrew Haydon, Susan E. Evans, Paul Cashin, Lara Lipton, Neil D. Merrett, James G. Kench, Peter Tagkalidis, Cuong Duong, Ashika D. Maharaj, Ri Scarborough, Liane Ioannou, Jennifer Philip, Charles H.C. Pilgrim, Peter Evans, Michael Michael, Rachel E. Neale, Julie Chu, David Goldstein, Ahmad Aly, J. Holland, Wendy A. Brown, Daniel Croagh
Publikováno v:
BMJ Open
PurposeThe Upper Gastrointestinal Cancer Registry (UGICR) was developed to monitor and improve the quality of care provided to patients with upper gastrointestinal cancers in Australia.ParticipantsIt supports four cancer modules: pancreatic, oesophag
Autor:
Andrew Haydon, Jessica C. Hassel, Meghan J. Mooradian, Mario E. Lacouture, Paras Mehta, Fei Ye, Prachi Bhave, Alexander M. Menzies, Allison Betof Warner, Tracey S Otto, Farzana Y Zaman, Jeffrey A. Sosman, Douglas B. Johnson, Ryan J. Sullivan, Steven T. Chen, Anna K. Dewan, Nicholas Kurtansky, Matteo S. Carlino, Sunandana Chandra, Briana R. Halle, Florentia Dimitriou, Georgina V. Long, Jacob S Choi, Veronica Rotemberg, Rebecca Irlmeier
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
BackgroundImmune checkpoint inhibitors (ICIs) are approved to treat multiple cancers. Retrospective analyses demonstrate acceptable safety of ICIs in most patients with autoimmune disease, although disease exacerbation may occur. Psoriasis vulgaris i
Autor:
Vanna Chiarion-Sileni, M. Mandal, A. Hauschild, Bijoyesh Mookerjee, R. Ji, Jeffrey J. Legos, John M. Kirkwood, Victoria Atkinson, Jacob Schachter, James Larkin, Richard F. Kefford, Ping Zhang, Caroline Robert, Caroline Dutriaux, M. Santinami, Andrew Haydon, Dirk Schadendorf, Georgina V. Long, Thierry Lesimple, Reinhard Dummer, Laurent Mortier, Marta Nyakas, Ruth Plummer
Publikováno v:
New England Journal of Medicine. 377:1813-1823
Combination therapy with the BRAF inhibitor dabrafenib plus the MEK inhibitor trametinib improved survival in patients with advanced melanoma with BRAF V600 mutations. We sought to determine whether adjuvant dabrafenib plus trametinib would improve o
Autor:
Alexander Menzies, Prachi Bhave, Alison Weppler, Lauren Julia Brown, Georgina V. Long, Douglas B. Johnson, Clara Allayous, Shahneen Sandhu, Andrew Haydon, Patrick A. Ott, J. Randall Patrinely, Matteo S. Carlino, Céleste Lebbé
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
BackgroundClinical trials of immunotherapy have excluded patients with pre-existing autoimmune disease. While the safety and efficacy of single agent ipilimumab and anti-PD1 antibodies in patients with autoimmune disease has been examined in retrospe